Restricted accessResearch articleFirst published online 2022-05
Psychopharmacological Strategies Employing Guanfacine in an Adolescent Girl with Postural Orthostatic Tachycardia Syndrome and Severe Posttraumatic Stress Disorder
AkinsanyaA, MarwahaR, TampiRR: Prazosin in children and adolescents with posttraumatic stress disorder who have nightmares: A systematic review. J Clin Psychopharmacol, 37:84–88, 2017.
2.
AndersonJ, WangC, ZaidiA, RiceT, CoffeyBJ: Guanfacine as a treatment for posttraumatic stress disorder in an adolescent female. J Child Adolesc Psychopharmacol, 30:398–401, 2020.
3.
ArnoldAC, NgJ, RajSR: Postural tachycardia syndrome—Diagnosis, physiology, and prognosis. Auton Neurosci, 215:3–11, 2018.
4.
AuxéméryY: [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context]. Encephale, 38:373–380, 2012.
5.
BiedermanJ, MelmedRD, PatelA, McBurnettK, DonahueJ, LyneA: Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr, 13:1047–1055, 2008.
6.
BorisJR: Postural orthostatic tachycardia syndrome in children and adolescents. Auton Neurosci, 215:97–101, 2018.
7.
BreretonA, McGlincheyE: Self-harm, emotion regulation, and experiential avoidance: A systematic review. Arch Suicide Res, 24:1–24, 2020.
8.
BrudeyC, ParkJ, WiaderkiewiczJ, KobayashiI, MellmanTA, MarvarPJ: Autonomic and inflammatory consequences of posttraumatic stress disorder and the link to cardiovascular disease. Am J Physiol Regul Integr Comp Physiol, 309:R315-21, 2015.
9.
ChenG, DuJ, JinH, HuangY: Postural tachycardia syndrome in children and adolescents: Pathophysiology and clinical management. Front Pediatr, 8:474, 2020.
10.
CohenJA, BuksteinO, WalterH, BensonSR, ChrismanA, FarchioneTR, HamiltonJ, KeableH, KinlanJ, SchoettleU, SiegelM, StockS, Medicus J; AACAP Work Group on QualityIssues: Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry, 49:414–430, 2010.
11.
ConnorDF, GrassoDJ, SlivinskyMD, PearsonGS, BangaA: An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. J Child Adolesc Psychopharmacol, 23:244–251, 2013.
12.
DeblingerE, MannarinoAP, CohenJA, RunyonMK, HeflinAH: Theory, treatment development, and research. In: Child Sexual Abuse: A Primer for Treating Children, Adolescents, and Their Nonoffending Parents. Edited by DeblingerE, MannarinoAP, CohenJA, RunyonMK, Heflin AH. New York, NY: Oxford University Press, 2015, pp. 19–42.
FerrafiatV, SoleimaniM, ChaumetteB, MartinezA, GuiléJ-M, KeeshinB, GerardinP: Use of prazosin for pediatric post-traumatic stress disorder with nightmares and/or sleep disorder: Case series of 18 patients prospectively assessed. Front Psychiatry, 11:724, 2020.
15.
FreemanR, WielingW, AxelrodFB, BendittDG, BenarrochE, BiaggioniI, CheshireWP, ChelimskyT, CortelliP, GibbonsCH, GoldsteinDS, HainsworthR, HilzMJ, JacobG, KaufmannH, JordanJ, LipsitzLA, LevineBD, LowPA, MathiasC, RajSR, RobertsonD, SandroniP, SchatzI, SchondorffR, StewartJM, van DijkJG: Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res, 21:69–72, 2011.
16.
HudsonN, BurghartS, ReynoldsonJ, GrauerD: Evaluation of low dose prazosin for PTSD-associated nightmares in children and adolescents. Ment Heal Clin, 11:45–49, 2021.
17.
KeeshinBR, DingQ, PressonAP, BerkowitzSJ, StrawnJR: Use of prazosin for pediatric PTSD-associated nightmares and sleep disturbances: A retrospective chart review. Neurol Ther, 6:247–257, 2017.
18.
KeeshinBR, StrawnJR: Psychological and pharmacologic treatment of youth with posttraumatic stress disorder: An evidence-based review. Child Adolesc Psychiatr Clin N Am, 23:399–411, x, 2014.
19.
KizilbashSJ, AhrensSP, BruceBK, ChelimskyG, DriscollSW, Harbeck-WeberC, LloydRM, MackKJ, NelsonDE, NinisN, PianosiPT, StewartJM, WeissKE, FischerPR: Adolescent fatigue, POTS, and recovery: A guide for clinicians. Curr Probl Pediatr Adolesc Health Care, 44:108–133, 2014.
20.
MeyerC, MühlsteffJ, DrexelT, EickholtC, KelmM, ZahiragicL, ZieglerD: POTS following traumatic stress: Interacting central and intracardiac neural control?. J Diabetes Complications, 29:459–461, 2015.
21.
MoonJ, KimD-Y, ByunJ-I, SunwooJ-S, LimJ-A, KimT-J, ShinJ-W, LeeW-J, LeeHS, JunJ-S, ParkK-I, JungK-H, LeeS-T, JungK-Y, ChuK, LeeSK: Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome. Health Qual Life Outcomes, 14:144, 2016.
22.
PatelDR, FeuchtC, BrownK, RamsayJ: Pharmacological treatment of anxiety disorders in children and adolescents: A review for practitioners. Transl Pediatr, 7:23–35, 2018.
23.
RajSR: The Postural Tachycardia Syndrome (POTS): Pathophysiology, diagnosis & management. Indian Pacing Electrophysiol J, 6:84–99, 2006.